down arrow

Concord Drugs

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Drugs
  • ISIN: INE858L01010
  • NSEID:
  • BSEID: 538965
INR
31.87
0.87 (2.81%)
BSENSE

Apr 11, 12:51 PM

BSE+NSE Vol: 1.18 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationNine Monthly Results
Results Snapshot
Figures in Rs cr
Consolidate Nine Monthly Results
Dec'24
Dec'23
Dec'22
Net Sales
34.86
29.29
39.79
Other Operating Income
0.00
0.00
0.00
Total Operating income
34.86
29.29
39.79
Raw Material Cost
27.16
21.83
30.53
Purchase of Finished goods
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.16
-1.82
0.44
Employee Cost
3.39
4.39
3.62
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
0.01
-0.01
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
1.05
1.20
1.57
Total Expenditure (Excl Depreciation)
31.77
25.59
36.16
Operating Profit (PBDIT) excl Other Income
3.09
3.70
3.63
Other Income
0.00
0.00
0.00
Operating Profit (PBDIT)
3.09
3.70
3.63
Interest
1.42
1.37
1.21
Exceptional Items
0.00
0.00
0.00
Gross Profit (PBDT)
1.67
2.33
2.42
Depreciation
1.05
1.16
1.30
Profit Before Tax
0.64
1.17
1.11
Tax
0.34
0.36
0.28
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
0.30
0.81
0.82
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
0.30
0.81
0.82
Share in Profit of Associates
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
0.30
0.81
0.82
Equity Capital
10.00
10.00
8.74
Face Value
10.0
10.0
10.0
Reserves
24.11
24.17
21.48
Diluted Earnings per share
0.23
-0.24
0.52
Operating Profit Margin (Excl OI)
8.86%
12.63%
9.12%
Gross Profit Margin
4.79%
7.95%
6.08%
PAT Margin
0.86%
2.77%
2.06%
Public Share Holdings (%)
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
Nine Monthly Analysis Highlights
stock-summary

Net Sales

YoY Growth in nine months ended Dec 2024 is 19.02% vs -26.39% in Dec 2023

stock-summary

Consolidate Net Profit

YoY Growth in nine months ended Dec 2024 is -62.96% vs -1.22% in Dec 2023

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in nine months ended Dec 2024 is -16.49% vs 1.93% in Dec 2023

stock-summary

Interest

YoY Growth in nine months ended Dec 2024 is 3.65% vs 13.22% in Dec 2023

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in nine months ended Dec 2024 has fallen from Dec 2023

Compare Nine Monthly Results Of Concord Drugs With
Markets Mojo
Figures in Rs cr
Consolidate Nine Monthly Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
Net Sales
34.86
9,199.93
-9,165.07
-99.62%
Other Operating Income
0.00
0.00
0.00
Total Operating income
34.86
9,199.93
-9,165.07
-99.62%
Raw Material Cost
27.16
1,471.08
-1,443.92
-98.15%
Purchase of Finished goods
0.00
1,244.57
-1,244.57
-100.00%
(Increase) / Decrease In Stocks
0.16
-93.01
93.17
100.17%
Employee Cost
3.39
1,989.92
-1,986.53
-99.83%
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
0.01
0.00
0.01
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
1.05
2,225.77
-2,224.72
-99.95%
Total Expenditure (Excl Depreciation)
31.77
6,838.33
-6,806.56
-99.54%
Operating Profit (PBDIT) excl Other Income
3.09
2,361.60
-2,358.51
-99.87%
Other Income
0.00
287.35
-287.35
-100.00%
Operating Profit (PBDIT)
3.09
2,648.95
-2,645.86
-99.88%
Interest
1.42
238.94
-237.52
-99.41%
Exceptional Items
0.00
0.00
0.00
Gross Profit (PBDT)
1.67
2,410.01
-2,408.34
-99.93%
Depreciation
1.05
405.66
-404.61
-99.74%
Profit Before Tax
0.64
2,007.79
-2,007.15
-99.97%
Tax
0.34
427.80
-427.46
-99.92%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
0.30
1,576.55
-1,576.25
-99.98%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
0.30
1,576.55
-1,576.25
-99.98%
Share in Profit of Associates
0.00
9.92
-9.92
-100.00%
Minority Interest
0.00
-7.70
7.70
100.00%
Other related items
0.00
0.00
0.00
Consolidated Net Profit
0.30
1,570.19
-1,569.89
-99.98%
Equity Capital
10.00
40.06
-30.06
-75.04%
Face Value
10.00
1.00
0.00
Reserves
24.11
0.00
24.11
Gross Profit Margin
4.79%
26.20%
0.00
-21.41%
PAT Margin
0.86%
17.14%
0.00
-16.28%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0.00%
0.00
0.00%
Nine Monthly - Net Sales
Net Sales 34.86 Cr
in Dec 2024

Figures in Rs Cr
stock-summary

YoY Growth in nine months ended Dec 2024 is 19.02% vs -26.39% in Dec 2023

Nine Monthly - Consolidate Net Profit
Consolidate Net Profit 0.30 Cr
in Dec 2024

Figures in Rs Cr
stock-summary

YoY Growth in nine months ended Dec 2024 is -62.96% vs -1.22% in Dec 2023

Nine Monthly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 3.09 Cr
in Dec 2024

Figures in Rs Cr
stock-summary

YoY Growth in nine months ended Dec 2024 is -16.49% vs 1.93% in Dec 2023

Nine Monthly - Interest
Interest 1.42 Cr
in Dec 2024

Figures in Rs Cr
stock-summary

YoY Growth in nine months ended Dec 2024 is 3.65% vs 13.22% in Dec 2023

Nine Monthly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 8.86%
in Dec 2024

Figures in Rs %
stock-summary

YoY Growth in nine months ended Dec 2024 has fallen from Dec 2023